NYC 9/11 Public Portal Document
Mr. Cuti -2- July 21, 2000
The success of our diarrheal outbreak detection program has clearly demonstrated
that an important indicator of disease occurrence is the sale of certain medications.
Since many persons who become ill will visit their pharmacy to purchase over-the-
counter medication before pursuing any other medical care (e.g., before seeing their
physician), increased drug sales could provide us with the earliest possible warning
of a disease outbreak. Recognizing the value of an early warning system using
pharmaceutical data, we would like to improve and expand our drug surveillance
program to monitor for a wider range of potential disease outbreaks including
influenza, waterborne diseases and bioterrorism.
Since your company operates numerous drug stores in the City, we would
appreciate your considering participation in this program. This would entail
providing us with timely summary statistics on the daily volume sales of specific
anti-diarrheal medications and flu or cough/cold remedies. Any data provided would
be used solely for public health purposes, and would be handled confidentially.
Your cooperation is voluntary but essential and would represent a valuable civic
service. We would appreciate the opportunity to meet with you, and/or appropriate
members of your company, to answer any questions that you may have and to
further discuss our possible partnership. Please address your response to this
request to Annie Fine, M.D., at the phone number listed below. Thank you very much
for your attention to this important matter.
Contact Person: Annie Fine, M.D.
Assistant Medical Director
Communicable Disease Program
New York City Department of Health
125 Worth Street, Room 300, CN-22A
New York, New York 10013
(212) 788-9635
NYC-WTC 000138003
OCR can misread numbers and units. Confirm readings against the page image before using them.